Interferons in Relapsing-Remitting Multiple Sclerosis: Are There Benefits from Long-Term Use?

By Oscar Fernández  

CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. : 1057-1070

Adis International

Access to resources Recommend Favorite

Social Functioning: Should it Become an Endpoint in Trials of Antidepressants?

By Bech Per  

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite

How Do Different Age Groups Use Benzodiazepines and Antidepressants?: Analysis of an Australian Administrative Database, 2003-6

By Smith Alesha J.   Tett Sue E.  

Drugs & Aging, Vol. 26, Iss. 2, 2009-01 ,pp. : 113-122

Adis International

Access to resources Recommend Favorite

Do Nanomedicines Require Novel Safety Assessments to Ensure their Safety for Long-Term Human Use?

By Hoet Peter   Legiest Barbara   Geys Jorina   Nemery Benoit  

Drug Safety, Vol. 32, Iss. 8, 2009-08 ,pp. : 625-636

Adis International

Access to resources Recommend Favorite

Incidence and determinants of long-term use of antidepressants

By Meijer Welmoed   Heerdink E.   Leufkens Hubert   Herings Ron   Egberts Antoine   Nolen Willem  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 1, 2004-03 ,pp. : 57-61

Springer Publishing Company

Access to resources Recommend Favorite